Ackermann, J

Investigating the role of activated telomerase in genetically engineered neuroblastoma mouse models

Adebiyi, FD

Efficacy of Allicin on DMBA-Induced BRCA-1 Defective Breast Carcinoma in Wistar Rats

Ahlert, H

Therapeutic stratification of acute leukemia using high throughput drug screening

Albert, C

Therapy assessment of pediatric chronic myeloid leukemia (CML) using combined analyses of RNA/DNA response dynamics

Alejo-Valle, O

Investigating miR-125b target gene Arid3a in trisomy 21-associated leukemogenesis

Mapping chromatin occupancy of GATA1 and RUNX1 isoforms in Down syndrome myeloid leukemia

Ali, S

Enhancer hijacking on the MYCN amplicon in neuroblastoma

Alsadeq, A

CD79a/CD79b Promote CNS-Involvement and Leukemic Engraftment in Pediatric B-cell Precursor Acute Lymphoblastic Leukemia

Amstislavskiy, V

Investigating miR-125b target gene Arid3a in trisomy 21-associated leukemogenesis

CRISPR/Cas9-based screens identify an essential long noncoding RNA locus in pediatric acute myeloid leukemia cells

Ezh2 loss cooperates with loss of Runx1 during leukemogenesis and reactivates a fetal gene signature

Antunes, E

Identification of the cell of origin in infant MLL-AF9 leukaemia

Atapina, E

A cost-effective quasi single-cell assay for deciphering of clonal architecture of leukemic cells

Bardinet, V

Genome-wide CRISPRa screen identifies determinants of Actinomycin-D resistance in alveolar rhabdomyosarcoma

Bartram, J

Deciphering STAT3 dependency in paediatric acute lymphoblastic leukemia

Barwinski, N

cf-DNA and EVs: Biomarkers for early detection of second primary malignancies in patients with heritable retinoblastoma

Bei, Y

Genome-wide CRISPRa screen identifies determinants of Actinomycin-D resistance in alveolar rhabdomyosarcoma

Bergh, B

Efficient healthcare for children with cancer using telemedicine in intensive chemotherapy phases

Berry, P

Multi-drug chemotherapy dose optimisation in preclinical leukaemia models using HPLC-MS/MS

Bhatia, S

Therapeutic stratification of acute leukemia using high throughput drug screening

Bhayadia, R

Testing ABT-263 for the treatment of pediatric acute myeloid leukemia

Overcoming differentiation blockage by inhibition of LSD1 as novel therapeutic strategy in pediatric AML

CRISPR/Cas9-based screens identify an essential long noncoding RNA locus in pediatric acute myeloid leukemia cells

Blair, H

Whole-genome CRISPR screen as a tool to identify mechanism of relapse and potential targets for novel drug combinations

Specific targeting of RUNX1/ETO; delivery of siRNA using Lipid Nanoparticles in vitro and in vivo

Multi-drug chemotherapy dose optimisation in preclinical leukaemia models using HPLC-MS/MS

High-throughput imaging analysis for drug combination efficacy in childhood acute lymphoblastic leukaemia

Blunck, CB

Identification of cellular markers for the IKZF1plus subgroup of B-cell acute lymphoblastic leukemia

Boer, JM

MicroRNA - 497~195 cluster suppresses cell cycle progression by targeting CCND3/CDK4 in acute lymphoblastic leukemia

Boldrin, E

MicroRNA - 497~195 cluster suppresses cell cycle progression by targeting CCND3/CDK4 in acute lymphoblastic leukemia

Borkhardt, A

Therapeutic stratification of acute leukemia using high throughput drug screening

Bortoluzzi, S

MicroRNA - 497~195 cluster suppresses cell cycle progression by targeting CCND3/CDK4 in acute lymphoblastic leukemia

Bräuer-Hartmann, D

Mapping chromatin occupancy of GATA1 and RUNX1 isoforms in Down syndrome myeloid leukemia

Bulmer, D

High-throughput imaging analysis for drug combination efficacy in childhood acute lymphoblastic leukaemia

Cantilena, S

Deciphering STAT3 dependency in paediatric acute lymphoblastic leukemia

Cario, G

CD79a/CD79b Promote CNS-Involvement and Leukemic Engraftment in Pediatric B-cell Precursor Acute Lymphoblastic Leukemia

Immunotherapeutic co-targeting of CD38 and CD47 in T-cell acute lymphoblastic leukemia (T-ALL)

Carlet, M

CD79a/CD79b Promote CNS-Involvement and Leukemic Engraftment in Pediatric B-cell Precursor Acute Lymphoblastic Leukemia

Chamorro Gonzalez, R

Enhancer hijacking on the MYCN amplicon in neuroblastoma

Claus, R

MicroRNA - 497~195 cluster suppresses cell cycle progression by targeting CCND3/CDK4 in acute lymphoblastic leukemia

Cousins, A

CD79a/CD79b Promote CNS-Involvement and Leukemic Engraftment in Pediatric B-cell Precursor Acute Lymphoblastic Leukemia

Debatin, KM

MicroRNA - 497~195 cluster suppresses cell cycle progression by targeting CCND3/CDK4 in acute lymphoblastic leukemia

De Boer, J

Deciphering STAT3 dependency in paediatric acute lymphoblastic leukemia

Den Boer, ML

MicroRNA - 497~195 cluster suppresses cell cycle progression by targeting CCND3/CDK4 in acute lymphoblastic leukemia

Dienstbier, N

Therapeutic stratification of acute leukemia using high throughput drug screening

Diskowski, L

The function of CBP/p300 and BET-proteins in dependence of H3.3K27M mutation in diffuse intrinsic pontine glioma (DIPG)

Dorado Garcia, H

Genome-wide CRISPRa screen identifies determinants of Actinomycin-D resistance in alveolar rhabdomyosarcoma

Ecker, J

Enhancing the effect of class I HDAC inhibition in MYC amplified group 3 medulloblastoma with novel drug combinations

Ehl, C

Mapping chromatin occupancy of GATA1 and RUNX1 isoforms in Down syndrome myeloid leukemia

ElHarouni, D

Enhancing the effect of class I HDAC inhibition in MYC amplified group 3 medulloblastoma with novel drug combinations

Emerenciano, M

Identification of cellular markers for the IKZF1plus subgroup of B-cell acute lymphoblastic leukemia

Emmrich, S

Investigating miR-125b target gene Arid3a in trisomy 21-associated leukemogenesis

Enzenmüller, S

Characterization of mechanisms of acquired Venetoclax-insensitivity in B-cell precursor acute lymphoblastic leukemia

Erlacher, M

Identification of novel therapeutic approaches in a xenograft model of juvenile myelomonocytic leukemia (JMML)

Fischer, J

Investigating the role of activated telomerase in genetically engineered neuroblastoma mouse models

Fischer, M

Investigating the role of activated telomerase in genetically engineered neuroblastoma mouse models

Fischer, U

Therapeutic stratification of acute leukemia using high throughput drug screening

Frielitz, FS

Efficient healthcare for children with cancer using telemedicine in intensive chemotherapy phases

Gaffo, E

MicroRNA - 497~195 cluster suppresses cell cycle progression by targeting CCND3/CDK4 in acute lymphoblastic leukemia

Gasparoli, L

Deciphering STAT3 dependency in paediatric acute lymphoblastic leukemia

Gialesaki, S

Mapping chromatin occupancy of GATA1 and RUNX1 isoforms in Down syndrome myeloid leukemia

Glauche, I

Therapy assessment of pediatric chronic myeloid leukemia (CML) using combined analyses of RNA/DNA response dynamics

Gottschalk, A

Therapy assessment of pediatric chronic myeloid leukemia (CML) using combined analyses of RNA/DNA response dynamics

Graf, N

Combined infection with oncolytic viruses (OVs) induces synergistic and additive cell death in glioblastoma multiforme (GBM) cell lines

Grimm, J

Overcoming differentiation blockage by inhibition of LSD1 as novel therapeutic strategy in pediatric AML

Haase, K

Genome-wide CRISPRa screen identifies determinants of Actinomycin-D resistance in alveolar rhabdomyosarcoma

Halsey, C

miR-128a and miR-130b determine lineage choice and leukemia-propagating cell identity in MLL-AF4+ acute leukemia

CD79a/CD79b Promote CNS-Involvement and Leukemic Engraftment in Pediatric B-cell Precursor Acute Lymphoblastic Leukemia

Hauer, J

Therapeutic stratification of acute leukemia using high throughput drug screening

Heckl, D

Testing ABT-263 for the treatment of pediatric acute myeloid leukemia

Investigating miR-125b target gene Arid3a in trisomy 21-associated leukemogenesis

Overcoming differentiation blockage by inhibition of LSD1 as novel therapeutic strategy in pediatric AML

CRISPR/Cas9-based screens identify an essential long noncoding RNA locus in pediatric acute myeloid leukemia cells

Mapping chromatin occupancy of GATA1 and RUNX1 isoforms in Down syndrome myeloid leukemia

Characterization of RNA-Protein Interaction Networks in Acute Leukemias

Rewiring the interplay between GATA1s and secondary mutations in the leukaemogenic transformation

Ezh2 loss cooperates with loss of Runx1 during leukemogenesis and reactivates a fetal gene signature

Heidenreich, O

Whole-genome CRISPR screen as a tool to identify mechanism of relapse and potential targets for novel drug combinations

Specific targeting of RUNX1/ETO; delivery of siRNA using Lipid Nanoparticles in vitro and in vivo

Multi-drug chemotherapy dose optimisation in preclinical leukaemia models using HPLC-MS/MS

Helmsauer, K

Enhancer hijacking on the MYCN amplicon in neuroblastoma

Helwig, M

Characterization of RNA-Protein Interaction Networks in Acute Leukemias

Henssen, A

Genome-wide CRISPRa screen identifies determinants of Actinomycin-D resistance in alveolar rhabdomyosarcoma

Henssen, AG

Enhancer hijacking on the MYCN amplicon in neuroblastoma

Hielscher, T

Enhancing the effect of class I HDAC inhibition in MYC amplified group 3 medulloblastoma with novel drug combinations

Hobeika, E

CD79a/CD79b Promote CNS-Involvement and Leukemic Engraftment in Pediatric B-cell Precursor Acute Lymphoblastic Leukemia

Hoell, JI

Characterization of RNA-Protein Interaction Networks in Acute Leukemias

Huynh, AKD

Combined infection with oncolytic viruses (OVs) induces synergistic and additive cell death in glioblastoma multiforme (GBM) cell lines

Inglott, S

Deciphering STAT3 dependency in paediatric acute lymphoblastic leukemia

Irving, J

High-throughput imaging analysis for drug combination efficacy in childhood acute lymphoblastic leukaemia

Issa, H

Specific targeting of RUNX1/ETO; delivery of siRNA using Lipid Nanoparticles in vitro and in vivo

Mapping chromatin occupancy of GATA1 and RUNX1 isoforms in Down syndrome myeloid leukemia

Rewiring the interplay between GATA1s and secondary mutations in the leukaemogenic transformation

Jeremias, I

CD79a/CD79b Promote CNS-Involvement and Leukemic Engraftment in Pediatric B-cell Precursor Acute Lymphoblastic Leukemia

Jian, Xu

Ezh2 loss cooperates with loss of Runx1 during leukemogenesis and reactivates a fetal gene signature

Jumaa, H

CD79a/CD79b Promote CNS-Involvement and Leukemic Engraftment in Pediatric B-cell Precursor Acute Lymphoblastic Leukemia

Kahlert, Y

Investigating the role of activated telomerase in genetically engineered neuroblastoma mouse models

Kellner, C

Immunotherapeutic co-targeting of CD38 and CD47 in T-cell acute lymphoblastic leukemia (T-ALL)

Ketteler, P

cf-DNA and EVs: Biomarkers for early detection of second primary malignancies in patients with heritable retinoblastoma

Klusmann, JH

Testing ABT-263 for the treatment of pediatric acute myeloid leukemia

Investigating miR-125b target gene Arid3a in trisomy 21-associated leukemogenesis

Overcoming differentiation blockage by inhibition of LSD1 as novel therapeutic strategy in pediatric AML

CRISPR/Cas9-based screens identify an essential long noncoding RNA locus in pediatric acute myeloid leukemia cells

Mapping chromatin occupancy of GATA1 and RUNX1 isoforms in Down syndrome myeloid leukemia

Characterization of RNA-Protein Interaction Networks in Acute Leukemias

Rewiring the interplay between GATA1s and secondary mutations in the leukaemogenic transformation

Ezh2 loss cooperates with loss of Runx1 during leukemogenesis and reactivates a fetal gene signature

Knoess, S

Ezh2 loss cooperates with loss of Runx1 during leukemogenesis and reactivates a fetal gene signature

Koche, RP

Enhancer hijacking on the MYCN amplicon in neuroblastoma

Koleci, N

Identification of novel therapeutic approaches in a xenograft model of juvenile myelomonocytic leukemia (JMML)

Komech, E

A cost-effective quasi single-cell assay for deciphering of clonal architecture of leukemic cells

Komkov, A

High-throughput sequencing of Ig/TCR genes for MRD monitoring in B-ALL patients receiving immunotherapy

A cost-effective quasi single-cell assay for deciphering of clonal architecture of leukemic cells

Kowarz, E

The role of reciprocal fusions in MLL-r acute leukemia: studying t(6;11) fusion proteins

Small changes in the MLL-AF4 fusion protein make a difference

Kramm, CM

The function of CBP/p300 and BET-proteins in dependence of H3.3K27M mutation in diffuse intrinsic pontine glioma (DIPG)

Comparison of Curcumin and Curcuminoids in terms of mechanisms of action and treatment efficiency in DIPG

Krumbholz, M

Therapy assessment of pediatric chronic myeloid leukemia (CML) using combined analyses of RNA/DNA response dynamics

Kubiak, K

The function of CBP/p300 and BET-proteins in dependence of H3.3K27M mutation in diffuse intrinsic pontine glioma (DIPG)

Kundu, A

The role of reciprocal fusions in MLL-r acute leukemia: studying t(6;11) fusion proteins

Labuhn, M

Investigating miR-125b target gene Arid3a in trisomy 21-associated leukemogenesis

Landua, SL

miR-128a and miR-130b determine lineage choice and leukemia-propagating cell identity in MLL-AF4+ acute leukemia

Law, E

Whole-genome CRISPR screen as a tool to identify mechanism of relapse and potential targets for novel drug combinations

Law, EW

High-throughput imaging analysis for drug combination efficacy in childhood acute lymphoblastic leukaemia

Lebedev, Y

A cost-effective quasi single-cell assay for deciphering of clonal architecture of leukemic cells

Lenk, L

CD79a/CD79b Promote CNS-Involvement and Leukemic Engraftment in Pediatric B-cell Precursor Acute Lymphoblastic Leukemia

Lohmann, D

cf-DNA and EVs: Biomarkers for early detection of second primary malignancies in patients with heritable retinoblastoma

Lopes, BA

Identification of cellular markers for the IKZF1plus subgroup of B-cell acute lymphoblastic leukemia

Lunec, J

High-throughput imaging analysis for drug combination efficacy in childhood acute lymphoblastic leukaemia

Malouf, C

miR-128a and miR-130b determine lineage choice and leukemia-propagating cell identity in MLL-AF4+ acute leukemia

Mamedov, I

High-throughput sequencing of Ig/TCR genes for MRD monitoring in B-ALL patients receiving immunotherapy

A cost-effective quasi single-cell assay for deciphering of clonal architecture of leukemic cells

Mansur, MB

Identification of cellular markers for the IKZF1plus subgroup of B-cell acute lymphoblastic leukemia

Marschalek, R

Role of reciprocal fusions in MLL-r acute leukemia: studying t(4;11) fusion proteins

The role of reciprocal fusions in MLL-r acute leukemia: studying t(6;11) fusion proteins

Small changes in the MLL-AF4 fusion protein make a difference

Maschan, M

High-throughput sequencing of Ig/TCR genes for MRD monitoring in B-ALL patients receiving immunotherapy

A cost-effective quasi single-cell assay for deciphering of clonal architecture of leukemic cells

Matzk, S

Ezh2 loss cooperates with loss of Runx1 during leukemogenesis and reactivates a fetal gene signature

McKenzie, L

Whole-genome CRISPR screen as a tool to identify mechanism of relapse and potential targets for novel drug combinations

High-throughput imaging analysis for drug combination efficacy in childhood acute lymphoblastic leukaemia

Metzler, M

Therapy assessment of pediatric chronic myeloid leukemia (CML) using combined analyses of RNA/DNA response dynamics

Meyer, LH

Characterization of mechanisms of acquired Venetoclax-insensitivity in B-cell precursor acute lymphoblastic leukemia

MicroRNA - 497~195 cluster suppresses cell cycle progression by targeting CCND3/CDK4 in acute lymphoblastic leukemia

Milde, T

Enhancing the effect of class I HDAC inhibition in MYC amplified group 3 medulloblastoma with novel drug combinations

Minari, JB

Efficacy of Allicin on DMBA-Induced BRCA-1 Defective Breast Carcinoma in Wistar Rats

Miroshnichenkova, A

High-throughput sequencing of Ig/TCR genes for MRD monitoring in B-ALL patients receiving immunotherapy

A cost-effective quasi single-cell assay for deciphering of clonal architecture of leukemic cells

Mir-Salim, D

Testing ABT-263 for the treatment of pediatric acute myeloid leukemia

Müller, K

Immunotherapeutic co-targeting of CD38 and CD47 in T-cell acute lymphoblastic leukemia (T-ALL)

Mundlos, S

Enhancer hijacking on the MYCN amplicon in neuroblastoma

Nakjang, S

Whole-genome CRISPR screen as a tool to identify mechanism of relapse and potential targets for novel drug combinations

Ng, M

Investigating miR-125b target gene Arid3a in trisomy 21-associated leukemogenesis

CRISPR/Cas9-based screens identify an essential long noncoding RNA locus in pediatric acute myeloid leukemia cells

Niedermayer, A

Characterization of mechanisms of acquired Venetoclax-insensitivity in B-cell precursor acute lymphoblastic leukemia

Niemeyer, CM

Identification of novel therapeutic approaches in a xenograft model of juvenile myelomonocytic leukemia (JMML)

Oehme, I

Enhancing the effect of class I HDAC inhibition in MYC amplified group 3 medulloblastoma with novel drug combinations

Olshanskaya, Y

High-throughput sequencing of Ig/TCR genes for MRD monitoring in B-ALL patients receiving immunotherapy

A cost-effective quasi single-cell assay for deciphering of clonal architecture of leukemic cells

Oppermann, S

Enhancing the effect of class I HDAC inhibition in MYC amplified group 3 medulloblastoma with novel drug combinations

Ottersbach, K

miR-128a and miR-130b determine lineage choice and leukemia-propagating cell identity in MLL-AF4+ acute leukemia

Identification of the cell of origin in infant MLL-AF9 leukaemia

Pal, D

Whole-genome CRISPR screen as a tool to identify mechanism of relapse and potential targets for novel drug combinations

High-throughput imaging analysis for drug combination efficacy in childhood acute lymphoblastic leukaemia

Peipp, M

Immunotherapeutic co-targeting of CD38 and CD47 in T-cell acute lymphoblastic leukemia (T-ALL)

Peterziel, H

Enhancing the effect of class I HDAC inhibition in MYC amplified group 3 medulloblastoma with novel drug combinations

Plass, C

MicroRNA - 497~195 cluster suppresses cell cycle progression by targeting CCND3/CDK4 in acute lymphoblastic leukemia

Popov, A

High-throughput sequencing of Ig/TCR genes for MRD monitoring in B-ALL patients receiving immunotherapy

A cost-effective quasi single-cell assay for deciphering of clonal architecture of leukemic cells

Poubel, CP

Identification of cellular markers for the IKZF1plus subgroup of B-cell acute lymphoblastic leukemia

Rademacher, AV

Efficient healthcare for children with cancer using telemedicine in intensive chemotherapy phases

Rajak, J

Identification of novel therapeutic approaches in a xenograft model of juvenile myelomonocytic leukemia (JMML)

Regenyi, E

CRISPR/Cas9-based screens identify an essential long noncoding RNA locus in pediatric acute myeloid leukemia cells

Mapping chromatin occupancy of GATA1 and RUNX1 isoforms in Down syndrome myeloid leukemia

Regényi, E

Characterization of RNA-Protein Interaction Networks in Acute Leukemias

Remke, M

Therapeutic stratification of acute leukemia using high throughput drug screening

Rösner, T

Immunotherapeutic co-targeting of CD38 and CD47 in T-cell acute lymphoblastic leukemia (T-ALL)

Sahm, F

miR-128a and miR-130b determine lineage choice and leukemia-propagating cell identity in MLL-AF4+ acute leukemia

Salaudeen, BO

Efficacy of Allicin on DMBA-Induced BRCA-1 Defective Breast Carcinoma in Wistar Rats

Schewe, DM

Efficient healthcare for children with cancer using telemedicine in intensive chemotherapy phases

CD79a/CD79b Promote CNS-Involvement and Leukemic Engraftment in Pediatric B-cell Precursor Acute Lymphoblastic Leukemia

Immunotherapeutic co-targeting of CD38 and CD47 in T-cell acute lymphoblastic leukemia (T-ALL)

Schliehe-Diecks, J

Therapeutic stratification of acute leukemia using high throughput drug screening

Schneider, D

Ezh2 loss cooperates with loss of Runx1 during leukemogenesis and reactivates a fetal gene signature

Schöpflin, R

Enhancer hijacking on the MYCN amplicon in neuroblastoma

Schrappe, M

Immunotherapeutic co-targeting of CD38 and CD47 in T-cell acute lymphoblastic leukemia (T-ALL)

Schulte, JH

Enhancer hijacking on the MYCN amplicon in neuroblastoma

Schuschel, K

Characterization of RNA-Protein Interaction Networks in Acute Leukemias

Schwarzer, A

Ezh2 loss cooperates with loss of Runx1 during leukemogenesis and reactivates a fetal gene signature

Semper, S

Therapy assessment of pediatric chronic myeloid leukemia (CML) using combined analyses of RNA/DNA response dynamics

Seyfried, F

Characterization of mechanisms of acquired Venetoclax-insensitivity in B-cell precursor acute lymphoblastic leukemia

Siemund, A

Small changes in the MLL-AF4 fusion protein make a difference

Singh, M

Multi-drug chemotherapy dose optimisation in preclinical leukaemia models using HPLC-MS/MS

Smirnova, A

A cost-effective quasi single-cell assay for deciphering of clonal architecture of leukemic cells

Smola, S

Combined infection with oncolytic viruses (OVs) induces synergistic and additive cell death in glioblastoma multiforme (GBM) cell lines

Sönnichsen, M

Therapeutic stratification of acute leukemia using high throughput drug screening

Stilgenbauer, S

Characterization of mechanisms of acquired Venetoclax-insensitivity in B-cell precursor acute lymphoblastic leukemia

Suttorp, M

Therapy assessment of pediatric chronic myeloid leukemia (CML) using combined analyses of RNA/DNA response dynamics

Swart, LE

Specific targeting of RUNX1/ETO; delivery of siRNA using Lipid Nanoparticles in vitro and in vivo

Szoltysek, K

Whole-genome CRISPR screen as a tool to identify mechanism of relapse and potential targets for novel drug combinations

High-throughput imaging analysis for drug combination efficacy in childhood acute lymphoblastic leukaemia

Tausch, E

Characterization of mechanisms of acquired Venetoclax-insensitivity in B-cell precursor acute lymphoblastic leukemia

Te Kronnie, G

MicroRNA - 497~195 cluster suppresses cell cycle progression by targeting CCND3/CDK4 in acute lymphoblastic leukemia

Thakur, BK

cf-DNA and EVs: Biomarkers for early detection of second primary malignancies in patients with heritable retinoblastoma

Tirtakusuma, R

Whole-genome CRISPR screen as a tool to identify mechanism of relapse and potential targets for novel drug combinations

Valerius, T

Immunotherapeutic co-targeting of CD38 and CD47 in T-cell acute lymphoblastic leukemia (T-ALL)

Valieva, M

Enhancer hijacking on the MYCN amplicon in neuroblastoma

Virely, C

Deciphering STAT3 dependency in paediatric acute lymphoblastic leukemia

Vogiatzi, F

Immunotherapeutic co-targeting of CD38 and CD47 in T-cell acute lymphoblastic leukemia (T-ALL)

Volchkov, E

High-throughput sequencing of Ig/TCR genes for MRD monitoring in B-ALL patients receiving immunotherapy

Vollmer, J

Enhancing the effect of class I HDAC inhibition in MYC amplified group 3 medulloblastoma with novel drug combinations

Volz, C

Therapy assessment of pediatric chronic myeloid leukemia (CML) using combined analyses of RNA/DNA response dynamics

von Stebut, J

Genome-wide CRISPRa screen identifies determinants of Actinomycin-D resistance in alveolar rhabdomyosarcoma

Vormoor, J

Whole-genome CRISPR screen as a tool to identify mechanism of relapse and potential targets for novel drug combinations

High-throughput imaging analysis for drug combination efficacy in childhood acute lymphoblastic leukaemia

Walch-Rückheim, B

Combined infection with oncolytic viruses (OVs) induces synergistic and additive cell death in glioblastoma multiforme (GBM) cell lines

Warnatz, HJ

Ezh2 loss cooperates with loss of Runx1 during leukemogenesis and reactivates a fetal gene signature

Weigert, K

Investigating miR-125b target gene Arid3a in trisomy 21-associated leukemogenesis

Werr, LH

Investigating the role of activated telomerase in genetically engineered neuroblastoma mouse models

Wiese, M

The function of CBP/p300 and BET-proteins in dependence of H3.3K27M mutation in diffuse intrinsic pontine glioma (DIPG)

Comparison of Curcumin and Curcuminoids in terms of mechanisms of action and treatment efficiency in DIPG

Wilhelm, A

Role of reciprocal fusions in MLL-r acute leukemia: studying t(4;11) fusion proteins

Williams, O

Deciphering STAT3 dependency in paediatric acute lymphoblastic leukemia

Winterberg, D

Immunotherapeutic co-targeting of CD38 and CD47 in T-cell acute lymphoblastic leukemia (T-ALL)

Witt, O

Enhancing the effect of class I HDAC inhibition in MYC amplified group 3 medulloblastoma with novel drug combinations

Wu, Y

Identification of novel therapeutic approaches in a xenograft model of juvenile myelomonocytic leukemia (JMML)

Wunderlich, FT

Investigating the role of activated telomerase in genetically engineered neuroblastoma mouse models

Yaspo, ML

Investigating miR-125b target gene Arid3a in trisomy 21-associated leukemogenesis

CRISPR/Cas9-based screens identify an essential long noncoding RNA locus in pediatric acute myeloid leukemia cells

Mapping chromatin occupancy of GATA1 and RUNX1 isoforms in Down syndrome myeloid leukemia

Characterization of RNA-Protein Interaction Networks in Acute Leukemias

Ezh2 loss cooperates with loss of Runx1 during leukemogenesis and reactivates a fetal gene signature

Zastrow, J

Comparison of Curcumin and Curcuminoids in terms of mechanisms of action and treatment efficiency in DIPG

Zeschnigk, M

cf-DNA and EVs: Biomarkers for early detection of second primary malignancies in patients with heritable retinoblastoma

Zeuner, S

Enhancing the effect of class I HDAC inhibition in MYC amplified group 3 medulloblastoma with novel drug combinations